Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity.
EBioMedicine
; 3: 67-78, 2016 Jan.
Article
en En
| MEDLINE
| ID: mdl-26870818
Palabras clave
Adjuvant; BME, beta mercaptoethanol; CD, cluster of differentiation; DSCF, Dwass, Steel, Critchlow-Fligner; Durable protection; ELISA, Enzyme linked immunosorbent assay; ELISPOT, enzyme-linked immunospot assay; Ebola virus; FACS, fluorescence activated cell sorting; FBS, fetal bovine serum; GP, glycoprotein; IACUC, Institutional Animal Care and Use Committee; IM, intramuscular; IP, intraperitoneal; IQR, interquartile range; Immune correlates; LN, lymph node; MPLA, monophosphoryl lipid A; NAb, neutralizing antibody; Ns, not significant; PBS, phosphate buffered saline; PRR, pattern recognition receptor; Pfu, plaque forming unit; PsVNA, pseudovirion neutralization assay; TLR, Toll-like receptor; USAMRIID, United States Army Medical Research Institute of Infectious Diseases; VLP, virus-like particle; Vaccine; ma-EBOV, mouse-adapted Ebola virus
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Vacunas
/
Linfocitos T CD4-Positivos
/
Adyuvantes Inmunológicos
/
Inmunidad
Límite:
Animals
Idioma:
En
Revista:
EBioMedicine
Año:
2016
Tipo del documento:
Article
País de afiliación:
Estados Unidos